Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 16,352 | 7,324 | 1,912 | 0 | 0 |
| Cost of Goods | 2,356 | 1,376 | 426 | N/A | N/A |
| Gross Profit | 13,996 | 5,948 | 1,486 | N/A | N/A |
| Operating Expenses | 85,148 | 83,624 | 71,866 | 70,557 | 35,659 |
| Operating Income | -70,796 | -77,300 | -69,954 | -69,875 | -35,659 |
| Interest Expense | 18,484 | 17,764 | 17,168 | 13,029 | 10,107 |
| Other Income | 3,703 | 3,618 | 4,270 | 3,334 | 2,523 |
| Pre-tax Income | -85,577 | -91,446 | -82,852 | -79,570 | -43,243 |
| Net Income Continuous | -85,577 | -91,446 | -82,852 | -79,570 | -43,243 |
| Net Income | $-85,577 | $-91,446 | $-82,852 | $-79,570 | $-43,243 |
| EPS Basic Total Ops | -1.32 | -1.56 | -1.42 | -1.44 | -0.76 |
| EPS Basic Continuous Ops | -1.32 | -1.56 | -1.42 | -1.43 | -0.76 |
| EPS Diluted Total Ops | -1.32 | -1.56 | -1.42 | -1.44 | -0.76 |
| EPS Diluted Continuous Ops | -1.32 | -1.56 | -1.42 | -1.43 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -1.32 | -1.35 | -1.42 | N/A | N/A |
| EBITDA(a) | $-70,016 | $-76,603 | $-69,266 | $-69,806 | $-34,996 |